Both in Pharmaceuticals
Immix Biopharma vs Obsidian Therapeutics
Over the past year IMMX returned −31.2% and OBX returned −21.7%; their daily moves had a correlation of 0.39.
IMMX −31.2% OBX −21.7%Growth of $1, one year, split-adjusted
| Metric | IMMX | OBX |
|---|---|---|
| Price | $8.35 | $13.94 |
| Market cap | $692.2M | $861.1M |
| Today | −1.88% | +0.07% |
| 1 month | −29.9% | −8.7% |
| 6 months | −17.9% | — |
| Year to date | +59.7% | — |
| 1 year | +162.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $232.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 72.8% | — |
| Short % of float | 21.8% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).